XGN News and Press, Exagen Inc.

2026-03-10 18:50:50 ET More on Exagen Exagen Inc. (XGN) Q4 2025 Earnings Call Transcript Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag Seeking Alpha’s Quant Rating on Exagen Historical earnings data...

2026-03-10 18:50:17 ET Exagen Inc. (XGN) Q4 2025 Earnings Call March 10, 2026 8:30 AM EDT Company Participants Tina Jacobsen John Aballi - CEO, President & Director Jeffrey Black - CFO & Corporate Secretary ... Read the full article on Seeking Alp...

2026-03-10 08:03:25 ET More on Exagen Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag Seeking Alpha’s Quant Rating on Exagen Historical earnings data for Exagen Financial information for Exagen ...

Record full-year total revenue and AVISE ® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today ...

Blend Labs Inc. Class A (BLND) is expected to report $-0.02 for Q4 2025 United Natural Foods Inc. (UNFI) is expected to report $0.51 for Q2 2026 Consumer Portfolio Services Inc. (CPSS) is expected to report $0.23 for Q4 2025 Westrock Coffee Company (WEST) is expected to report $-0.1 f...

2026-03-08 09:30:25 ET More on Avino Silver & Gold Mines Ltd., Harmony Gold Mining, etc. Zumtobel Group AG (ZMTBY) Q3 2026 Earnings Call Transcript Zumtobel Group AG 2026 Q3 - Results - Earnings Call Presentation Buy Oracle's 'Bubble Fears' Before Next Week's Q3 ...

CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended December 31, 2025, before the market opens on Tuesday, March 10, 2026. John Aballi, President and Chief Executiv...

CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth quarter and year ended December 31, 2025, in line with prior financial guidance. Select Prelimi...

CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences: 16 th Annual Craig-Hallum Alpha Select Conference Date:...

2025-11-04 15:57:15 ET More on Exagen Exagen Inc. (XGN) Q3 2025 Earnings Call Transcript Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now Exagen GAAP EPS of -$0.31 misses by $0.15, revenue of $17.24M beats by $0.34M Seeking Alpha’s...